,Date,News Headline,Article Link,Source
0,2022-01-12 17:00,Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/travere-therapeutics-reports-inducement-grants-220000434.html,GlobeNewswire
1,2022-01-11 10:54,Health Check: How Prudently Does Travere Therapeutics (NASDAQ:TVTX) Use Debt?,https://finance.yahoo.com/news/health-check-prudently-does-travere-155429455.html,Simply Wall St.
2,2022-01-10 07:00,Travere Therapeutics Provides Corporate Update and 2022 Outlook,https://finance.yahoo.com/news/travere-therapeutics-provides-corporate-2022-120000336.html,GlobeNewswire
3,2022-01-04 16:30,"Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer",https://finance.yahoo.com/news/travere-therapeutics-appoints-jula-inrig-213000737.html,GlobeNewswire
4,2021-12-15 07:00,Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria,https://finance.yahoo.com/news/travere-therapeutics-announces-positive-topline-120000286.html,GlobeNewswire
5,2021-12-14 16:30,Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/travere-therapeutics-reports-inducement-grants-213000263.html,GlobeNewswire
6,2021-12-12 15:50,"Travere Therapeutics, Inc. (TVTX) Fell Out Of Favor With Hedge Funds?",https://finance.yahoo.com/news/travere-therapeutics-inc-tvtx-fell-205042743.html,Insider Monkey
7,2021-11-11 16:30,Travere Therapeutics to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/travere-therapeutics-present-upcoming-investor-213000745.html,GlobeNewswire
8,2021-11-02 16:30,Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021,https://finance.yahoo.com/news/travere-therapeutics-present-abstracts-american-203000608.html,GlobeNewswire
9,2021-10-28 16:01,Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress,https://finance.yahoo.com/news/travere-therapeutics-reports-third-quarter-200100378.html,GlobeNewswire
10,2021-10-14 16:30,Travere Therapeutics to Report Third Quarter 2021 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-report-third-quarter-203000851.html,GlobeNewswire
11,2021-10-13 17:00,Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/travere-therapeutics-reports-inducement-grants-210000414.html,GlobeNewswire
12,2021-10-12 17:00,Travere Therapeutics Announces Transition of Chief Medical Officer,https://finance.yahoo.com/news/travere-therapeutics-announces-transition-chief-210000529.html,GlobeNewswire
13,2021-10-12 13:07,Travere Therapeutics' (NASDAQ:TVTX) growing losses don't faze investors as the stock increases 4.7% this past week,https://finance.yahoo.com/news/travere-therapeutics-nasdaq-tvtx-growing-170707735.html,Simply Wall St.
14,2021-09-16 01:00,"Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand",https://finance.yahoo.com/news/vifor-pharma-travere-therapeutics-announce-050000301.html,Business Wire
15,2021-09-15 16:05,"Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand",https://finance.yahoo.com/news/travere-therapeutics-vifor-pharma-announce-200500807.html,GlobeNewswire
16,2021-09-14 16:30,Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors,https://finance.yahoo.com/news/travere-therapeutics-appoints-ruth-williams-203000474.html,GlobeNewswire
17,2021-09-13 17:00,Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/travere-therapeutics-reports-inducement-grants-210000672.html,GlobeNewswire
18,2021-09-07 08:00,Travere Therapeutics Announces Successful Outcome from Type A Meeting with U.S. FDA for Sparsentan in Focal Segmental Glomerulosclerosis,https://finance.yahoo.com/news/travere-therapeutics-announces-successful-outcome-120000278.html,GlobeNewswire
19,2021-08-16 07:00,Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy,https://finance.yahoo.com/news/travere-therapeutics-announces-positive-topline-110000690.html,GlobeNewswire
20,2021-07-29 16:01,Travere Therapeutics Reports Second Quarter 2021 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-reports-second-quarter-200100021.html,GlobeNewswire
21,2021-07-22 16:30,Travere Therapeutics to Report Second Quarter 2021 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-report-second-quarter-203000932.html,GlobeNewswire
22,2021-07-14 16:30,Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/travere-therapeutics-reports-inducement-grants-203000558.html,GlobeNewswire
23,2021-07-13 09:56,Health Check: How Prudently Does Travere Therapeutics (NASDAQ:TVTX) Use Debt?,https://finance.yahoo.com/news/health-check-prudently-does-travere-135603397.html,Simply Wall St.
24,2021-06-07 22:47,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX",https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-024700570.html,GlobeNewswire
25,2021-06-05 19:52,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX",https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-235200473.html,Newsfile
26,2021-06-04 08:00,Travere Therapeutics Announces Presentation of Abstracts at ERA-EDTA Congress 2021,https://finance.yahoo.com/news/travere-therapeutics-announces-presentation-abstracts-120000970.html,GlobeNewswire
27,2021-06-02 23:01,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX",https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-030100256.html,GlobeNewswire
28,2021-06-02 08:00,Travere Therapeutics Completes Enrollment in Pivotal Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy,https://finance.yahoo.com/news/travere-therapeutics-completes-enrollment-pivotal-120000487.html,GlobeNewswire
29,2021-06-01 05:35,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX",https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-093500144.html,PR Newswire
30,2021-05-29 23:01,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX",https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-030100069.html,Newsfile
31,2021-05-27 16:30,Travere Therapeutics to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/travere-therapeutics-present-upcoming-investor-203000835.html,GlobeNewswire
32,2021-05-26 16:10,"Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Travere Therapeutics, Inc. (TVTX) Investigation",https://finance.yahoo.com/news/bronstein-gewirtz-grossman-llc-notifies-201000302.html,ACCESSWIRE
33,2021-05-25 16:01,Travere Therapeutics Provides Regulatory Update on Sparsentan Development Program for Focal Segmental Glomerulosclerosis,https://finance.yahoo.com/news/travere-therapeutics-provides-regulatory-sparsentan-200100776.html,GlobeNewswire
34,2021-05-06 16:01,Travere Therapeutics Reports First Quarter 2021 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-reports-first-quarter-200100234.html,GlobeNewswire
35,2021-05-06 14:30,"Travere Therapeutics, Inc. to Host Earnings Call",https://finance.yahoo.com/news/travere-therapeutics-inc-host-earnings-183000720.html,ACCESSWIRE
36,2021-04-27 16:30,Travere Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference,https://finance.yahoo.com/news/travere-therapeutics-present-bofa-securities-203000968.html,GlobeNewswire
37,2021-04-26 16:30,Travere Therapeutics to Report First Quarter 2021 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-report-first-quarter-203000734.html,GlobeNewswire
38,2021-04-14 07:24,"What Type Of Shareholders Own The Most Number of Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares?",https://finance.yahoo.com/news/type-shareholders-own-most-number-112459491.html,Simply Wall St.
39,2021-03-01 16:01,Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-reports-fourth-quarter-210100713.html,GlobeNewswire
40,2021-03-01 14:30,"Travere Therapeutics, Inc. to Host Earnings Call",https://finance.yahoo.com/news/travere-therapeutics-inc-host-earnings-193000974.html,ACCESSWIRE
41,2021-02-25 08:00,Travere Therapeutics Recognizes Rare Disease Day 2021 and the Importance of Working Together to Innovate and Address Healthcare Disparities in Rare Disease,https://finance.yahoo.com/news/travere-therapeutics-recognizes-rare-disease-130000085.html,GlobeNewswire
42,2021-02-22 16:30,Travere Therapeutics to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/travere-therapeutics-present-upcoming-investor-213000542.html,GlobeNewswire
43,2021-02-18 16:30,Travere Therapeutics Announces European Commission Has Granted Orphan Designation to Sparsentan for the Treatment of IgA Nephropathy,https://finance.yahoo.com/news/travere-therapeutics-announces-european-commission-213000131.html,GlobeNewswire
44,2021-02-17 16:05,Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters Option to Purchase Additional Shares,https://finance.yahoo.com/news/travere-therapeutics-announces-completion-public-210500587.html,GlobeNewswire
45,2021-02-16 16:30,Travere Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results,https://finance.yahoo.com/news/travere-therapeutics-report-fourth-quarter-213000846.html,GlobeNewswire
46,2021-02-11 22:03,Travere Therapeutics Announces Pricing of Public Offering of Common Stock,https://finance.yahoo.com/news/travere-therapeutics-announces-pricing-public-030300680.html,GlobeNewswire
47,2021-02-10 16:01,Travere Therapeutics Announces Proposed Public Offering of Common Stock,https://finance.yahoo.com/news/travere-therapeutics-announces-proposed-public-210100074.html,GlobeNewswire
48,2021-02-10 08:18,Can You Imagine How Jubilant Travere Therapeutics' (NASDAQ:TVTX) Shareholders Feel About Its 112% Share Price Gain?,https://finance.yahoo.com/news/imagine-jubilant-travere-therapeutics-nasdaq-131838325.html,Simply Wall St.
49,2021-02-02 07:00,Travere Therapeutics Announces Achievement of Interim Proteinuria Endpoint in the Ongoing Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis,https://finance.yahoo.com/news/travere-therapeutics-announces-achievement-interim-120000263.html,GlobeNewswire
50,2021-01-12 16:30,Travere Therapeutics Announces Orphan Drug Designation for Sparsentan for the Treatment of IgA Nephropathy,https://finance.yahoo.com/news/travere-therapeutics-announces-orphan-drug-213000566.html,GlobeNewswire
51,2021-01-11 07:00,Travere Therapeutics Provides Corporate Update and 2021 Outlook,https://finance.yahoo.com/news/travere-therapeutics-provides-corporate-2021-120000021.html,GlobeNewswire
52,2020-12-01 16:30,"Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020",https://finance.yahoo.com/news/travere-therapeutics-host-virtual-r-213000138.html,GlobeNewswire
